Nanocarriers in gene therapy: A review

Journal of Biomedical Nanotechnology

Volumn 10, Issue 12, 2014, Pages 3483-3507

  Xu, Hongpan ^a   Li, Zhiyang ^a   Si, Jin ^a  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Combinations therapy; Gene therapy; Liposomes; Nanocarriers; Polymeric nanoparticles; RNA interference technique

Indexed keywords

DISEASE CONTROL; DISEASES; DRUG THERAPY; GENE TRANSFER; GENES; LIPOSOMES; NANOPARTICLES; NUCLEIC ACIDS; OLIGONUCLEOTIDES; RNA; SEMICONDUCTOR QUANTUM DOTS; VECTORS;

ANTISENSE OLIGONUCLEOTIDES; CLINICAL APPLICATION; CLINICAL INTERVENTIONS; COMBINATIONS THERAPY; NANO-CARRIERS; POLYMERIC NANOPARTICLES; RNA INTERFERENCE; SMALL INTERFERING RNA;

GENE THERAPY;

ANTISENSE OLIGONUCLEOTIDE; NANOCARRIER; NANOMATERIAL; DNA; NANOCAPSULE;

GENE DELIVERY SYSTEM; GENE INACTIVATION; GENE TARGETING; GENE THERAPY; GENETIC COMPLEMENTATION; HUMAN; REVIEW; RNA INTERFERENCE; SUICIDE GENE THERAPY; TARGETED GENE REPAIR; CHEMISTRY; DRUG DESIGN; GENETIC TRANSFECTION; GENETICS; PROCEDURES; ULTRASTRUCTURE;

DNA; DRUG DESIGN; GENETIC THERAPY; HUMANS; NANOCAPSULES; TRANSFECTION;

EID: 84907095890     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.2044     Document Type: Review

References (305)

1. T. Wirth, N. Parker, and S. Yla-Herttuala, History of gene therapy. Gene 525, 162 (2013).
2. N. He, X. Zeng, W. Wang, K. Deng, Y. Pan, L. Xiao, J. Zhang, and K. Li, Challenges and future expectations of reversed gene therapy. J. Nanosci. Nanotechnol. 11, 8634 (2011).
3. K. G. Lee, J. C. Kim, R. Wi, J. S. Min, J. K. Ahn, and H. K. Do, Synthesis of stable silica-dye hybrid nanomaterial as DNA carrier. J. Nanosci. Nanotechnol. 11, 686 (2011).
4. T. Liu, X. Yu, B. Kan, Q. Guo, X. Wang, S. Shi, G. Guo, F. Luo, X. Zhao, Y. Wei, and Z. Qian, Enhanced gene delivery using biodegradable poly(ester amine)s (PEAs) based on low-molecularweight polyethylenimine and poly(epsilon-caprolactone)-pluronicpoly( epsilon-caprolactone). J. Biomed. Nanotechnol. 6, 351 (2010).
5. D. Kobelt, J. Aumann, M. Schmidt, B. Wittig, I. Fichtner, D. Behrens, M. Lemm, G. Freundt, P. M. Schlag, and W. Walther, Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector. Mol. Oncol. 8, 609 (2014).
6. J. S. Suk, A. J. Kim, K. Trehan, C. S. Schneider, L. Cebotaru, O. M. Woodward, N. J. Boylan, M. P. Boyle, S. K. Lai, W. B. Guggino, and J. Hanes, Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier. J. Control. Release 14, 8 (2014).
7. M. G. Vitor, J. M. Claudio, A. Q. Joao, P. Chantal, J. C. Ilidio, and S. Fani, Improved minicircle DNA biosynthesis for gene therapy applications. Hum. Gene Ther. Methods 25, 93 (2013).
8. E. Mosad, M. Abdou, and A. H. Zaky, Rearrangement of the myeloid/lymphoid leukemia gene in therapy-related myelodysplastic syndrome in patients previously treated with agents targeting DNA topoisomerase II. Oncology 83, 128 (2012).
9. F. Cramer, C. L. Christensen, T. T. Poulsen, M. A. Badding, D. A. Dean, and H. S. Poulsen, Insertion of a nuclear factor kappa B DNA nuclear-targeting sequence potentiates suicide gene therapy efficacy in lung cancer cell lines. Cancer Gene Ther. 19, 675 (2012).
10. V. Scaiewicz, V. Sorin, Y. Fellig, T. Birman, A. Mizrahi, J. Galula, R. Abu-Lail, T. Shneider, P. Ohana, L. Buscail, A. Hochberg, and A. Czerniak, Use of H19 gene regulatory sequences in DNA-based therapy for pancreatic cancer. J. Oncol. 2010, 178174 (2010).
11. A. Levina, Z. Ismagilov, M. Repkova, N. Shatskaya, N. Shikina, F. Tusikov, and V. Zarytova, Nanocomposites consisting of titanium dioxide nanoparticles and oligonucleotides. J. Nanosci. Nanotechnol. 12, 1812 (2012).
12. Y. S. Kim, I. K. Park, W. J. Kim, M. K. Yu, S. Jon, S. H. Pun, M. H. Jeong, and Y. Ahn, SPION nanoparticles as an efficient probe and carrier of DNA to umbilical cord blood-derived mesenchymal stem cells. J. Nanosci. Nanotechnol. 11, 1507 (2011).
13. Q. Yang, K. Wu, M. Ji, W. Jin, N. He, B. Shi, and P. Hou, Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients. J. Biomed. Nanotechnol. 9, 1607 (2013).
14. M. E. Davis, J. E. Zuckerman, C. H. Choi, D. Seligson, A. Tolcher, C. A. Alabi, Y. Yen, J. D. Heidel, and A. Ribas, Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067 (2010).
15. B. Singh, Y. J. Choi, I. K. Park, and T. Akaike, Chemical modification of chitosan with pH-sensitive molecules and specific ligands for efficient DNA transfection and siRNA silencing. J. Nanosci. Nanotechnol. 14, 564 (2014).
16. Q. Deng, Z. Zhang, X. Feng, T. Li, N. Liu, J. Lai, L. Shuai, Q. Xiong, C. Fu, H. Zou, Y. Wang, X. Li, K. Ma, and P. Bie, TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice. Gene Ther. 21, 317 (2014).
17. A. Janeczek, A. Zimna, N. Rozwadowska, M. Fraczek, P. Kucharzewska, M. Rucinski, T. Mietkiewski, T. Kolanowski, A. Malcher, and M. Kurpisz, Genetically modified human myoblasts with eNOS may improve regenerative ability of myogenic stem cells to infarcted heart. Kardiol. Pol. 71, 1048 (2013).
18. S. P. Forbes, I. S. Alferiev, M. Chorny, R. F. Adamo, R. J. Levy, and I. Fishbein, Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: Implications for gene therapy of restenosis. Atherosclerosis 230, 23 (2013).
19. W. Zhang, J. Wu, B. Qiao, W. Xu, and S. Xiong, Amelioration of lupus nephritis by serum amyloid P component gene therapy with distinct mechanisms varied from different stage of the disease. PLoS One 6, 25 (2011).
20. K. N. Westlund, Gene therapy for pancreatitis pain. Gene Ther. 16, 483 (2009).
21. P. Ruff, K. D. Koh, H. Keskin, R. B. Pai, and F. Storici, Aptamerguided gene targeting in yeast and human cells. Nucleic Acids Res. 42, e61 (2014).
22. H. L. Li, T. Nakano, and A. Hotta, Genetic correction using engineered nucleases for gene therapy applications. Dev. Growth Differ. 56, 63 (2014).
23. N. Lachmann, C. Happle, M. Ackermann, D. Luttge, M. Wetzke, S. Merkert, M. Hetzel, G. Kensah, M. Jara-Avaca, A. Mucci, J. Skuljec, A. M. Dittrich, N. Pfaff, S. Brennig, A. Schambach, D. Steinemann, G. Gohring, T. Cantz, U. Martin, N. Schwerk, G. Hansen, and T. Moritz, Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 189, 167 (2014).
24. I. Brigida, A. V. Sauer, F. Ferrua, S. Giannelli, S. Scaramuzza, V. Pistoia, M. C. Castiello, B. H. Barendregt, M. P. Cicalese, M. Casiraghi, C. Brombin, J. Puck, K. Muller, L. D. Notarangelo, D. Montin, J. M. van Montfrans, M. G. Roncarolo, E. Traggiai, J. J. van Dongen, M. van der Burg, and A. Aiuti, B-cell development and functions and therapeutic options in adenosine deaminasedeficient patients. J. Allergy Clin. Immunol. 133, 799 (2014).
25. T. Tal-Goldberg, S. Lorain, and S. Mitrani-Rosenbaum, Correction of the middle eastern M712T mutation causing GNE myopathy by trans-splicing. Neuromolecular Med. 16, 322 (2013).
26. J. M. Powers and G. D. Trobridge, Identification of hematopoietic stem cell engraftment genes in gene therapy studies. J. Stem Cell Res. Ther. 2013, S3 (2013).
27. D. A. Carbonaro, L. Zhang, X. Jin, C. Montiel-Equihua, S. Geiger, M. Carmo, A. Cooper, L. Fairbanks, M. L. Kaufman, N. J. Sebire, R. P. Hollis, M. P. Blundell, S. Senadheera, P. Y. Fu, A. Sahaghian, R. Y. Chan, X. Wang, K. Cornetta, A. J. Thrasher, D. B. Kohn, and H. B. Gaspar, Preclinical demonstration of lentiviral vectormediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency. Mol. Ther. 22, 607 (2013).
28. R. A. Morgan, N. Chinnasamy, D. Abate-Daga, A. Gros, P. F. Robbins, Z. Zheng, M. E. Dudley, S. A. Feldman, J. C. Yang, R. M. Sherry, G. Q. Phan, M. S. Hughes, U. S. Kammula, A. D. Miller, C. J. Hessman, A. A. Stewart, N. P. Restifo, M. M. Quezado, M. Alimchandani, A. Z. Rosenberg, A. Nath, T. Wang, B. Bielekova, S. C. Wuest, N. Akula, F. J. McMahon, S. Wilde, B. Mosetter, D. J. Schendel, C. M. Laurencot, and S. A. Rosenberg, Cancer regression and neurological toxicity following anti-MAGEA 3TCR gene therapy. J. Immunother. 36, 133 (2013).
29. C. P. Dinney, M. B. Fisher, N. Navai, M. A. O'Donnell, D. Cutler, A. Abraham, S. Young, B. Hutchins, M. Caceres, N. Kishnani, G. Sode, C. Cullen, G. Zhang, H. B. Grossman, A. M. Kamat, M. Gonzales, M. Kincaid, N. Ainslie, D. C. Maneval, M. F. Wszolek, and W. F. Benedict, Phase I trial of intravesical recombinant adenovirus mediated interferon-alpha2b formulated in Syn3 for bacillus calmette-guerin failures in nonmuscle invasive bladder cancer. J. Urol. 190, 850 (2013).
30. C. Lu, D. J. Stewart, J. J. Lee, L. Ji, R. Ramesh, G. Jayachandran, M. I. Nunez, Wistuba, II, J. J. Erasmus, M. E. Hicks, E. A. Grimm, J. M. Reuben, V. Baladandayuthapani, N. S. Templeton, J. D. McMannis, and J. A. Roth, Phase I clinical trial of systemically administered TUSC2 (FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One 7, e34833 (2012).
31. P. Kebriaei, H. Huls, B. Jena, M. Munsell, R. Jackson, D. A. Lee, P. B. Hackett, G. Rondon, E. Shpall, R. E. Champlin, and L. J. Cooper, Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies. Hum. Gene Ther. 23, 444 (2012).
32. L. Coughlan, S. Vallath, A. Gros, M. Gimenez-Alejandre, N. Van Rooijen, G. J. Thomas, A. H. Baker, M. Cascallo, R. Alemany, and I. R. Hart, Combined fiber modifications both to target alpha(v)beta(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5. Hum. Gene Ther. 23, 960 (2012).
33. M. Lu, S. O. Freytag, H. Stricker, J. H. Kim, K. Barton, and B. Movsas, Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial). Contemp. Clin. Trials 32, 453 (2011).
34. K. Sampathkumar, S. Arulkumar, and M. Ramalingam, Advances in stimuli responsive nanobiomaterials for cancer therapy. J. Biomed. Nanotechnol. 10, 367 (2014).
35. H. Zhang, Multifunctional nanomedicine platforms for cancer therapy. J. Nanosci. Nanotechnol. 12, 4012 (2012).
36. Z. Ali, Y. Deng, and C. Ma, Progress of research in gastric cancer. J. Nanosci. Nanotechnol. 12, 8241 (2012).
37. K. J. Lee, J. H. An, J. S. Shin, and D. H. Kim, Synthesis and characterization of bicalutamide-loaded magnetic nanoparticles as anti-tumor drug carriers. J. Nanosci. Nanotechnol. 12, 1611 (2012).
38. H. Shimizu, Y. Hori, S. Kaname, K. Yamada, N. Nishiyama, S. Matsumoto, K. Miyata, M. Oba, A. Yamada, K. Kataoka, and T. Fujita, siRNA-based therapy ameliorates glomerulonephritis. J. Am. Soc. Nephrol. 21, 622 (2010).
39. J. Zhang, A. S. Li, X. Kou, L. Xiao, P. Li, N. He, and K. Li, Why CCR5 is chosen as the target for stem cell gene therapy for HIV infection? J. Nanosci. Nanotechnol. 12, 2045 (2012).
40. K. M. White, R. Alba, A. L. Parker, A. F. Wright, A. C. Bradshaw, C. Delles, R. A. McDonald, and A. H. Baker, Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile. J. Cardiothorac Surg. 8, 183 (2013).
41. M. Giacca and S. Zacchigna, VEGF gene therapy: Therapeutic angiogenesis in the clinic and beyond. Gene Ther. 19, 622 (2012).
42. D. A. Chistiakov, I. A. Sobenin, and A. N. Orekhov, Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology. Drug Deliv. 19, 392 (2012).
43. D. Rohde, H. Brinks, J. Ritterhoff, G. Qui, S. Ren, and P. Most, S100A1 gene therapy for heart failure: A novel strategy on the verge of clinical trials. J. Mol. Cell Cardiol. 50, 777 (2011).
44. Y. K. Kim, J. T. Kwon, H. L. Jiang, Y. J. Choi, M. H. Cho, and C. S. Cho, Kidney-specific peptide-conjugated poly(ester amine) for the treatment of kidney fibrosis. J. Nanosci. Nanotechnol. 12, 5149 (2012).
45. H. Fukui and Y. Raphael, Gene therapy for the inner ear. Hear Res. 297, 99 (2013).
46. S. B. Shibata, S. R. Cortez, J. A. Wiler, D. L. Swiderski, and Y. Raphael, Hyaluronic acid enhances gene delivery into the cochlea. Hum. Gene Ther. 23, 302 (2012).
47. N. Pan, B. Kopecky, I. Jahan, and B. Fritzsch, Understanding the evolution and development of neurosensory transcription factors of the ear to enhance therapeutic translation. Cell Tissue Res. 349, 415 (2012).
48. H. Wang, H. B. Shi, and S. K. Yin, Polyamidoamine dendrimers as gene delivery carriers in the inner ear: How to improve transfection efficiency. Exp. Ther. Med. 2, 777 (2011).
49. E. M. Sweet, S. Vemaraju, and B. B. Riley, Sox2 and Fgf interact with Atoh1 to promote sensory competence throughout the zebrafish inner ear. Dev. Biol. 358, 113 (2011).
50. I. Pyykko, J. Zou, W. Zhang, and Y. Zhang, Nanoparticle-based delivery for the treatment of inner ear disorders. Curr. Opin. Otolaryngol. Head Neck Surg. 19, 388 (2011).
51. D. M. Lipinski, M. Thake, and R. E. MacLaren, Clinical applications of retinal gene therapy. Prog. Retin. Eye Res. 32, 22 (2013).
52. C. N. Kuo, C. Y. Chen, S. N. Chen, L. C. Yang, L. J. Lai, C. H. Lai, M. F. Chen, C. H. Hung, and C. H. Chen, Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model. Int. J. Mol. Sci. 14, 8291 (2013).
53. J. Tereshchenko, A. Maddalena, M. Bahr, and S. Kugler, Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease. Neurobiol. Dis. 15, 35 (2014).
54. Y. Y. Liu, X. Y. Yang, Z. Li, Z. L. Liu, D. Cheng, Y. Wang, X. J. Wen, J. Y. Hu, J. Liu, L. M. Wang, and H. J. Wang, Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease. CNS Neurosci. Ther. 20, 76 (2014).
55. J. Navarro-Yepes, L. Zavala-Flores, A. Anandhan, F. Wang, M. Skotak, N. Chandra, M. Li, A. Pappa, D. Martinez-Fong, L. M. Del Razo, B. Quintanilla-Vega, and R. Franco, Antioxidant gene therapy against neuronal cell death. Pharmacol. Ther. 142, 206 (2013).
56. S. N. Kalburgi, N. N. Khan, and S. J. Gray, Recent gene therapy advancements for neurological diseases. Discov. Med. 15, 111 (2013).
57. A. Kwiatkowska, M. S. Nandhu, P. Behera, E. A. Chiocca, and M. S. Viapiano, Strategies in gene therapy for glioblastoma. Cancers 5, 1271 (2013).
58. Y. Du, X. Zhang, Q. Tao, S. Chen, and W. Le, Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson's disease. Neurodegener Dis. 11, 113 (2013).
59. A. Chtarto, O. Bockstael, T. Tshibangu, O. Dewitte, M. Levivier, and L. Tenenbaum, A next step in adeno-associated virus-mediated gene therapy for neurological diseases: Regulation and targeting. Br. J. Clin. Pharmacol. 76, 217 (2013).
60. J. Zhou, K. B. Atsina, B. T. Himes, G. W. Strohbehn, and W. M. Saltzman, Novel delivery strategies for glioblastoma. Cancer J. 18, 89 (2012).
61. K. M. Kroeger, A. K. Muhammad, G. J. Baker, H. Assi, M. K. Wibowo, W. Xiong, K. Yagiz, M. Candolfi, P. R. Lowenstein, and M. G. Castro, Gene therapy and virotherapy: Novel therapeutic approaches for brain tumors. Discov. Med. 10, 293 (2010).
62. X. Zhu, D. Su, S. Xuan, G. Ma, Z. Dai, T. Liu, D. Tang, W. Mao, and C. Dong, Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells. Gastric Cancer 16, 155 (2013).
63. S. H. Zhang, K. M. Wen, W. Wu, W. Y. Li, and J. N. Zhao, Efficacy of HGF carried by ultrasound microbubble-cationic nano-liposomes complex for treating hepatic fibrosis in a bile duct ligation rat model, and its relationship with the diffusion-weighted MRI parameters. Clin. Res. Hepatol. Gastroenterol. 37, 602 (2013).
64. H. Teoh, A. Quan, A. K. Creighton, K. W. A. Bang, K. K. Singh, P. C. Shukla, N. Gupta, Y. Pan, F. Lovren, H. Leong-Poi, M. Al- Omran, and S. Verma, BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis. Gene Ther. 20, 51 (2013).
65. Y. P. Sher, C. M. Chang, C. G. Juo, C. T. Chen, J. L. Hsu, C. Y. Lin, Z. Han, S. G. Shiah, and M. C. Hung, Targeted endostatincytosine deaminase fusion gene therapy plus 5-fluorocytosine suppresses ovarian tumor growth. Oncogene 32, 1082 (2013).
66. L. L. Policastro, I. L. Ibanez, C. Notcovich, H. A. Duran, and O. L. Podhajcer, The tumor microenvironment: Characterization, redox considerations, and novel approaches for reactive oxygen speciestargeted gene therapy. Antioxid. Redox Signal. 19, 854 (2013).
67. T. Oguchi, Y. Funahashi, H. Yokoyama, O. Nishizawa, W. F. Goins, J. R. Goss, J. C. Glorioso, and N. Yoshimura, Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception. Gene Ther. 20, 194 (2013).
68. F. M. Mowat, A. R. Breuwer, J. T. Bartoe, M. J. Annear, Z. Zhang, A. J. Smith, J. W. Bainbridge, S. M. Petersen-Jones, and R. R. Ali, RPE65 gene therapy slows cone loss in Rpe65-deficient dogs. Gene Ther. 20, 545 (2013).
69. S. Elangovan, S. Jain, P. C. Tsai, H. C. Margolis, and M. Amiji, Nano-sized calcium phosphate particles for periodontal gene therapy. J. Periodontol. 84, 117 (2013).
70. Y. Chen, G. Wang, D. Kong, Z. Zhang, K. Yang, R. Liu, W. Zhao, and Y. Xu, Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer. Mol. Carcinog. 52, 237 (2013).
71. I. Berindan-Neagoe, C. Braicu, O. Tudoran, O. Balacescu, and A. Irimie, Early apoptosis signals induced by a low dose of epigallocatechin 3-gallate interfere with apoptotic and cell death pathways. J. Nanosci. Nanotechnol. 12, 2113 (2012).
72. X. Li, Q. Lin, D. Wang, Y. Dai, K. Cheng, J. Yu, A. Lin, M. Gao, and A. Chen, The effects of low-intensity pulsed ultrasound and nanomagnet applications on the expressions of MMP-13 and MAPKs in rabbit knee osteoarthritis. J. Nanosci. Nanotechnol. 13, 722 (2013).
73. L. L. Ren, Y. Wu, D. Han, L. D. Zhao, Q. M. Sun, W. W. Guo, J. H. Sun, N. Wu, X. Q. Li, S. Q. Zhai, D. Y. Han, W. Y. Young, and S. M. Yang, Math1 gene transfer based on the delivery system of quaternized chitosan/Na-carboxymethyl-beta-cyclodextrin nanoparticles. J. Nanosci. Nanotechnol. 10, 7262 (2010).
74. H. J. Lee, Y. T. Nguyen, M. Muthiah, H. Vu-Quang, R. Namgung, W. J. Kim, M. K. Yu, S. Jon, I. K. Lee, Y. Y. Jeong, and I. K. Park, MR traceable delivery of p53 tumor suppressor gene by PEI-functionalized superparamagnetic iron oxide nanoparticles. J. Biomed. Nanotechnol. 8, 361 (2012).
75. J. H. Yoo and J. S. Kim, The specific hybridization of p53 gene on bead-quantum dot complex in microfluidic chip. J. Nanosci. Nanotechnol. 11, 7082 (2011).
76. J. Zhang, D. L. Zhang, X. L. Jiao, and Q. Dong, S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-kappaB-dependent MMP-9 signal. Eur. Rev. Med. Pharmacol. Sci. 17, 2372 (2013).
77. R. P. Wilkes, D. A. Ward, K. M. Newkirk, J. K. Adams, and S. A. Kania, Evaluation of delivery agents used for introduction of small interfering RNAs into feline corneal cells. Am. J. Vet. Res. 74, 243 (2013).
78. P. Thai, S. Statt, C. H. Chen, E. Liang, C. Campbell, and R. Wu, Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. Am. J. Respir. Cell. Mol. Biol. 49, 204 (2013).
79. J. Tabernero, G. I. Shapiro, P. M. LoRusso, A. Cervantes, G. K. Schwartz, G. J. Weiss, L. Paz-Ares, D. C. Cho, J. R. Infante, M. Alsina, M. M. Gounder, R. Falzone, J. Harrop, A. C. White, I. Toudjarska, D. Bumcrot, R. E. Meyers, G. Hinkle, N. Svrzikapa, R. M. Hutabarat, V. A. Clausen, J. Cehelsky, S. V. Nochur, C. Gamba-Vitalo, A. K. Vaishnaw, D. W. Sah, J. A. Gollob, and H. A. Burris, First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov. 3, 406 (2013).
80. G. A. Perkins, G. R. Van de Walle, N. Pusterla, H. N. Erb, and N. Osterrieder, Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses. Am. J. Vet. Res. 74, 248 (2013).
81. W. Ma, Y. Liu, N. Ellison, and J. Shen, Induction of C-X-C chemokine receptor type 7 (CXCR7) switches stromal cell-derived factor-1 (SDF-1) signaling and phagocytic activity in macrophages linked to atherosclerosis. J. Biol. Chem. 288, 15481 (2013).
82. I. B. Neagoe, C. Braicu, C. Matea, C. Bele, G. Florin, K. Gabriel, C. Veronica, and A. Irimie, Efficient siRNA delivery system using carboxilated single-wall carbon nanotubes in cancer treatment. J. Biomed. Nanotechnol. 8, 567 (2012).
83. J. C. Trefry and D. P. Wooley, Silver nanoparticles inhibit vaccinia virus infection by preventing viral entry through a macropinocytosis-dependent mechanism. J. Biomed. Nanotechnol. 9, 1624 (2013).
84. K. H. Kim, I. Dmitriev, J. P. O'Malley, M. Wang, S. Saddekni, Z. You, M. A. Preuss, R. D. Harris, R. Aurigemma, G. P. Siegal, K. R. Zinn, D. T. Curiel, and R. D. Alvarez, A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer. Clin. Cancer Res. 18, 3440 (2012).
85. L. M. Finocchiaro and G. C. Glikin, Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow-up. Cancer Gene Ther. 19, 852 (2012).
86. A. Reschner, Y. H. Shim, P. Dubois, P. Delvenne, B. Evrard, L. Marcelis, C. Moucheron, A. Kirsch-De Mesmaeker, E. Defrancq, M. Raes, J. Piette, L. Collard, and G. Piel, Evaluation of a new biocompatible poly(N-(morpholino ethyl methacrylate))-based copolymer for the delivery of ruthenium oligonucleotides, targeting HPV16 E6 oncogene. J. Biomed. Nanotechnol. 9, 1432 (2013).
87. R. Chen, H. Yu, Y. L. An, Z. Yu-Jia, and G. J. Teng, Genetic immunotherapy for hepatocellular carcinoma by endothelial progenitor cells armed with cytosine deaminase. J. Biomed. Nanotechnol. 10, 271 (2014).
88. B. Shah, S. Kona, T. A. Gilbertson, and K. T. Nguyen, Effects of poly-(lactide-co-glycolide) nanoparticles on electrophysiological properties of enteroendocrine cells. J. Nanosci. Nanotechnol. 11, 3533 (2011).
89. A. M. Ribeiro, A. C. Souza, A. C. Amaral, N. M. Vasconcelos, M. S. Jeronimo, F. P. Carneiro, L. H. Faccioli, M. S. Felipe, C. L. Silva, and A. L. Bocca, Nanobiotechnological approaches to delivery of DNA vaccine against fungal infection. J. Biomed. Nanotechnol. 9, 221 (2013).
90. X. J. Li, L. Sun, L. Xiao, and F. Y. Liu, Gene delivery in peritoneal dialysis related peritoneal fibrosis research. Chin. Med. J. 125, 2219 (2012).
91. S. J. Howe and A. Chandrashekran, Vector systems for prenatal gene therapy: Principles of retrovirus vector design and production. Methods Mol. Biol. 891, 85 (2012).
92. F. G. Rocha, F. B. Calvo, K. C. Chaves, J. P. Peron, R. F. Marques, T. R. de Borba, M. S. Braga, C. B. Pereira, E. J. Vicente, R. Chammas, N. Schor, and M. H. Bellini, Endostatinand interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma. J. Gene Med. 13, 148 (2011).
93. Y. Kawasaki, A. Tamamoto, M. Takagi-Kimura, Y. Maeyama, N. Yamaoka, N. Terada, H. Okamura, N. Kasahara, and S. Kubo, Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma. Cancer Gene Ther. 18, 571 (2011).
94. C. Unzu, I. Melero, A. Morales-Kastresana, A. Sampedro, I. Serrano-Mendioroz, A. Azpilikueta, M. C. Ochoa, J. Dubrot, E. Martinez-Anso, and A. Fontanellas, Innate functions of immunoglobulin m lessen liver gene transfer with helper-dependent adenovirus. PLoS One 9, 21 (2014).
95. Y. M. Kang, Y. R. Choi, C. O. Yun, J. O. Park, K. S. Suk, H. S. Kim, M. S. Park, B. H. Lee, H. M. Lee, and S. H. Moon, Down-regulation of collagen synthesis and matrix metalloproteinase expression in myofibroblasts from dupuytren nodule using adenovirus-mediated relaxin gene therapy. J. Orthop. Res. 32, 515 (2014).
96. M. Chorny, I. Fishbein, J. E. Tengood, R. F. Adamo, I. S. Alferiev, and R. J. Levy, Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors. FASEB J. 27, 2198 (2013).
97. M. Westphal, S. Yla-Herttuala, J. Martin, P. Warnke, P. Menei, D. Eckland, J. Kinley, R. Kay, and Z. Ram, Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): A randomised, open-label, phase 3 trial. Lancet Oncol. 14, 823 (2013).
98. W. Wang, W. Ji, H. Hu, J. Ma, X. Li, W. Mei, Y. Xu, Y. Yan, Q. Song, Z. Li, and C. Su, Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy. Oncotarget 5, 150 (2014).
99. D. Uchida, H. Shiraha, H. Kato, T. Nagahara, M. Iwamuro, J. Kataoka, S. Horiguchi, M. Watanabe, A. Takaki, K. Nouso, Y. Nasu, T. Yagi, H. Kumon, and K. Yamamoto, Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer. J. Gastroenterol. Hepatol. 27, 12501 (2013).
100. Z. Liu, F. Ke, C. Duan, H. Lan, J. Li, C. Gao, and Z. Zhong, Mannan-conjugated adenovirus enhanced gene therapy effects on murine hepatocellular carcinoma cells in vitro and in vivo. Bioconjug. Chem. 24, 1387 (2013).
101. H. Chen, X. Zheng, B. Di, D. Wang, Y. Zhang, H. Xia, and Q. Mao, Aptamer modification improves the adenoviral transduction of malignant glioma cells. J. Biotechnol. 168, 362 (2013).
102. W. Wei, Y. Mu, X. Li, M. Gou, H. Zhang, S. Luo, K. Men, Y. Mao, Z. Qian, and L. Yang, Adenoviral vectors modified by heparinpolyethyleneimine nanogels enhance targeting to the lung and show therapeutic potential for pulmonary metastasis in vivo. J. Biomed. Nanotechnol. 7, 768 (2011).
103. C. Mueller, J. D. Chulay, B. C. Trapnell, M. Humphries, B. Carey, R. A. Sandhaus, N. G. McElvaney, L. Messina, Q. Tang, F. N. Rouhani, M. Campbell-Thompson, A. D. Fu, A. Yachnis, D. R. Knop, G. J. Ye, M. Brantly, R. Calcedo, S. Somanathan, L. P. Richman, R. H. Vonderheide, M. A. Hulme, T. M. Brusko, J. M. Wilson, and T. R. Flotte, Human treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression. J. Clin. Invest. 123, 5310 (2013).
104. Y. Cheng, L. Huang, X. Li, H. Qi, P. Zhou, W. Yu, Y. A. Jiang, S. Wadsworth, and A. Scaria, Prevalence of neutralizing factors against adeno-associated virus types 2 in age-related macular degeneration and polypoidal choroidal vasculopathy. Curr. Gene Ther. 13, 182 (2013).
105. G. Mittermeyer, C. W. Christine, K. H. Rosenbluth, S. L. Baker, P. Starr, P. Larson, P. L. Kaplan, J. Forsayeth, M. J. Aminoff, and K. S. Bankiewicz, Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Hum. Gene Ther. 23, 377 (2012).
106. S. G. Jacobson, A. V. Cideciyan, R. Ratnakaram, E. Heon, S. B. Schwartz, A. J. Roman, M. C. Peden, T. S. Aleman, S. L. Boye, A. Sumaroka, T. J. Conlon, R. Calcedo, J. J. Pang, K. E. Erger, M. B. Olivares, C. L. Mullins, M. Swider, S. Kaushal, W. J. Feuer, A. Iannaccone, G. A. Fishman, E. M. Stone, B. J. Byrne, and W. W. Hauswirth, Gene therapy for leber congenital amaurosis caused by RPE65 mutations: Safety and efficacy in 15 children and adults followed up to 3 years. Arch. Ophthalmol. 130, 9 (2012).
107. S. Herson, F. Hentati, A. Rigolet, A. Behin, N. B. Romero, F. Leturcq, P. Laforet, T. Maisonobe, R. Amouri, H. Haddad, M. Audit, M. Montus, C. Masurier, B. Gjata, C. Georger, M. Cherai, P. Carlier, J. Y. Hogrel, A. Herson, Y. Allenbach, F. M. Lemoine, D. Klatzmann, H. L. Sweeney, R. C. Mulligan, B. Eymard, D. Caizergues, T. Voit, and O. Benveniste, A phase I trial of adeno-associated virus serotype 1-gamma-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C. Brain 135, 483 (2012).
108. L. Di, Y. Zhu, J. Jia, J. Yu, G. Song, J. Zhang, L. Che, H. Yang, Y. Han, B. Ma, C. Zhang, Y. Yuan, M. You, F. Wan, X. Wang, X. Zhou, and J. Ren, Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients. Clin. Transl. Oncol. 14, 675 (2012).
109. D. E. Bowles, S. W. McPhee, C. Li, S. J. Gray, J. J. Samulski, A. S. Camp, J. Li, B. Wang, P. E. Monahan, J. E. Rabinowitz, J. C. Grieger, L. Govindasamy, M. Agbandje-McKenna, X. Xiao, and R. J. Samulski, Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol. Ther. 20, 443 (2012).
110. J. Bennett, M. Ashtari, J. Wellman, K. A. Marshall, L. L. Cyckowski, D. C. Chung, S. McCague, E. A. Pierce, Y. Chen, J. L. Bennicelli, X. Zhu, G. S. Ying, J. Sun, J. F. Wright, A. Auricchio, F. Simonelli, K. S. Shindler, F. Mingozzi, K. A. High, and A. M. Maguire, AAV2 gene therapy readministration in three adults with congenital blindness. Sci. Transl. Med. 4, 120ra15 (2012).
111. B. Wang, H. Qian, H. Yang, L. Xu, W. Xu, and J. Yan, Regression of atherosclerosis plaques in apolipoprotein E-/- mice after lentivirus-mediated RNA interference of CD40. Int. J. Cardiol. 163, 34 (2013).
112. B. T. van den Brand, E. A. Vermeij, C. E. Waterborg, O. J. Arntz, M. Kracht, M. B. Bennink, W. B. van den Berg, and F. A. van de Loo, Intravenous delivery of HIV-based lentiviral vectors preferentially transduces F4/80+ and Ly-6C+ cells in spleen, important target cells in autoimmune arthritis. PLoS One 8, e55356 (2013).
113. M. M. Segura, M. Mangion, B. Gaillet, and A. Garnier, New developments in lentiviral vector design, production and purification. Expert. Opin. Biol. Ther. 13, 987 (2013).
114. X. Zhang, L. Zhao, C. Chen, J. Yan, C. Zhou, G. Yue, L. Tian, and M. Zhang, The effect of lentivirus-mediated expression of tumor necrosis factor related apoptosis-inducing ligand and shRNA against Bcl-2 on the growth of lymphoma cells. Leuk. Lymphoma 53, 710 (2012).
115. C. Booth, C. Rivat, M. Alonso-Ferrero, M. Blundell, N. J. Sebire, A. J. Thrasher, and H. B. Gaspar, Lentiviral-vector-mediated gene therapy for X-linked lymphoproliferative disease restores humoral and cellular functions. Lancet 381, S25 (2013).
116. C. Heldermon, E. Qin, K. Ohlemiller, E. Herzog, J. Brown, C. Vogler, W. Hou, J. Orrock, B. Crawford, and M. Sands, Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice. Gene Ther. 20, 913 (2013).
117. J. C. Roth, M. Ismail, J. S. Reese, K. T. Lingas, G. Ferrari, and S. L. Gerson, Cotransduction with MGMT and ubiquitous or erythroid-specific GFP lentiviruses allows enrichment of dualpositive hematopoietic progenitor cells in vivo. ISRN Hematol. 2012, 212586 (2012).
118. H. Mannell, J. Pircher, T. Rathel, K. Schilberg, K. Zimmermann, A. Pfeifer, O. Mykhaylyk, B. Gleich, U. Pohl, and F. Krotz, Targeted endothelial gene delivery by ultrasonic destruction of magnetic microbubbles carrying lentiviral vectors. Pharm. Res. 29, 1282 (2012).
119. Y. Liu, C. Chen, H. He, D. Wang, L. E, Z. Liu, and H. Liu, Lentiviral-mediated gene transfer into human adipose-derived stem cells: role of NELL1 versus BMP2 in osteogenesis and adipogenesis in vitro. Acta. Biochim. Biophys. Sin. 44, 856 (2012).
120. A. Aiuti, L. Biasco, S. Scaramuzza, F. Ferrua, M. P. Cicalese, C. Baricordi, F. Dionisio, A. Calabria, S. Giannelli, and M. C. Castiello, Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341, 865 (2013).
121. T. Xiong, Y. Li, F. Ni, and F. Zhang, Monitoring of bystander effect of herpes simplex virus thymidine kinase/acyclovir system using fluorescence resonance energy transfer technique. J. Biomed. Nanotechnol. 8, 74 (2012).
122. M. A. Islam, J. Firdous, Y. J. Choi, C. H. Yun, and C. S. Cho, Regulation of endocytosis by non-viral vectors for efficient gene activity. J. Biomed. Nanotechnol. 10, 67 (2014).
123. L. Qu, M. Jiang, Z. Li, F. Pu, L. Gong, L. Sun, R. Gong, G. Ji, and J. Si, Inhibitory effect of biosynthetic nanoscale peptide melittin on hepatocellular carcinoma, driven by survivin promoter. J. Biomed. Nanotechnol. 10, 695 (2014).
124. A. Vilchis-Juarez, G. Ferro-Flores, C. Santos-Cuevas, E. Morales- Avila, B. Ocampo-Garcia, L. Diaz-Nieto, M. Luna-Gutierrez, N. Jimenez-Mancilla, M. Pedraza-Lopez, and L. Gomez-Olivan, Molecular targeting radiotherapy with cyclo-RGDFK(C) peptides conjugated to 177Lu-labeled gold nanoparticles in tumor-bearing mice. J. Biomed. Nanotechnol. 10, 393 (2014).
125. S. Kona, D. Specht, M. Rahimi, B. P. Shah, T. A. Gilbertson, and K. T. Nguyen, Targeted biodegradable nanoparticles for drug delivery to smooth muscle cells. J. Nanosci. Nanotechnol. 12, 236 (2012).
126. Y. C. Kim, P. J. Ludovice, and M. R. Prausnitz, Transdermal delivery enhanced by antimicrobial peptides. J. Biomed. Nanotechnol. 6, 612 (2010).
127. Z. He, Y. Yu, Y. Zhang, Y. Yan, Y. Zheng, J. He, Y. Xie, G. He, Y. Wei, and X. Song, Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor alpha. J. Biomed. Nanotechnol. 9, 833 (2013).
128. E. Maltas, M. Ozmen, B. Yildirimer, S. Kucukkolbasi, and S. Yildiz, Interaction between ketoconazole and human serum albumin on epoxy modified magnetic nanoparticles for drug delivery. J. Nanosci. Nanotechnol. 13, 6522 (2013).
129. Y. Lei, H. Tang, H. Zhong, H. Xie, R. Liu, M. Feng, and B. Zou, Labeling of hematopoietic stem cells by Tat peptide conjugated quantum dots for cell tracking in mouse body. J. Nanosci. Nanotechnol. 12, 6880 (2012).
130. K. Kim, J. H. Chang, and Y. J. Kang, Efficient internalization of peptide-conjugated SPIONs in dendritic cells for tumor targeting. J. Nanosci. Nanotechnol. 12, 5191 (2012).
131. L. Xin, J. Cao, H. Cheng, F. Zeng, and X. Hu, Stealth cationic liposomes modified with anti-CAGE single-chain fragment variable deliver recombinant methioninase for gastric carcinoma therapy. J. Nanosci. Nanotechnol. 13, 178 (2013).
132. A. Manosroi, W. Lohcharoenkal, F. Gotz, R. G. Werner, W. Manosroi, and J. Manosroi, Cellular uptake enhancement of Tat-GFP fusion protein loaded in elastic niosomes. J. Biomed. Nanotechnol. 7, 366 (2011).
133. D. Papakostas, F. Rancan, W. Sterry, U. Blume-Peytavi, and A. Vogt, Nanoparticles in dermatology. Arch. Dermatol. Res. 303, 533 (2011).
134. V. Sanz, H. M. Coley, S. R. Silva, and J. McFadden, Protamine and chloroquine enhance gene delivery and expression mediated by RNA-wrapped single walled carbon nanotubes. J. Nanosci. Nanotechnol. 12, 1739 (2012).
135. W. W. Yeo, H. Hosseinkhani, S. A. Rahman, R. Rosli, A. J. Domb, and S. Abdullah, Safety profile of dextran-spermine gene delivery vector in mouse lungs. J. Nanosci. Nanotechnol. 14, 3328 (2014).
136. L. Albarran, T. Lopez, P. Quintana, and V. Chagoya, Stability of hepatoprotecting agent IFC-305 encapsulated into sol-gel titania nanoparticles and drug release evaluation: Water and drug concentration effect. J. Nanosci. Nanotechnol. 12, 2199 (2012).
137. P. Soman, W. Zhang, A. Umeda, Z. J. Zhang, and S. Chen, Femtosecond laser-assisted optoporation for drug and gene delivery into single mammalian cells. J. Biomed. Nanotechnol. 7, 334 (2011).
138. R. Goyal, S. K. Tripathi, S. Tyagi, K. R. Ram, K. M. Ansari, P. Kumar, Y. Shukla, D. K. Chowdhuri, and K. C. Gupta, Gellan gum-PEI nanocomposites as efficient gene delivery agents. J. Biomed. Nanotechnol. 7, 38 (2011).
139. A. Nakhlband, J. Barar, A. Bidmeshkipour, H. R. Heidari, and Y. Omidi, Bioimpacts of anti epidermal growth factor receptor antisense complexed with polyamidoamine dendrimers in human lung epithelial adenocarcinoma cells. J. Biomed. Nanotechnol. 6, 360 (2010).
140. V. Saxena and M. D. Hussain, Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. J. Biomed. Nanotechnol. 9, 1146 (2013).
141. P. Ojer, L. Neutsch, F. Gabor, J. M. Irache, and A. L. de Cerain, Cytotoxicity and cell interaction studies of bioadhesive poly(anhydride) nanoparticles for oral antigen/drug delivery. J. Biomed. Nanotechnol. 9, 1891 (2013).
142. M. A. Moretton, D. A. Chiappetta, F. Andrade, J. das Neves, D. Ferreira, B. Sarmento, and A. Sosnik, Hydrolyzed galactomannan-modified nanoparticles and flower-like polymeric micelles for the active targeting of rifampicin to macrophages. J. Biomed. Nanotechnol. 9, 1076 (2013).
143. X. Deng, X. Xu, Y. Lai, B. He, and Z. Gu, Novel nanoparticles generated by polymeric amphiphiles with pi-pi conjugated small molecules for anti-tumor drug delivery. J. Biomed. Nanotechnol. 9, 1336 (2013).
144. T. M. de Araujo, Z. Teixeira, H. C. Barbosa-Sampaio, L. F. Rezende, A. C. Boschero, N. Duran, and N. F. Hoehr, Insulinloaded poly(epsilon-caprolactone) nanoparticles: Efficient, sustained and safe insulin delivery system. J. Biomed. Nanotechnol. 9, 1098 (2013).
145. N. Ma, C. Ma, Y. Deng, T. Wang, and N. He, Advances in applications of dendritic compounds. J. Nanosci. Nanotechnol. 13, 33 (2013).
146. E. Pedziwiatr-Werbicka, D. Shcharbin, J. Maly, M. Maly, M. Zaborski, B. Gabara, P. Ortega, F. J. de la Mata, R. Gomez, M. A. Munoz-Fernandez, B. Klajnert, and M. Bryszewska, Carbosilane dendrimers are a non-viral delivery system for antisense oligonucleotides: Characterization of dendriplexes. J. Biomed. Nanotechnol. 8, 57 (2012).
147. N. Wu, M. Li, Z. T. Chen, X. B. Zhang, H. Z. Liu, Z. Li, W. W. Guo, L. D. Zhao, L. L. Ren, J. N. Li, H. J. Yi, D. Han, W. Y. Yang, Y. Wu, and S. M. Yang, In vivo delivery of Atoh1 gene to rat cochlea using a dendrimer-based nanocarrier. J. Biomed. Nanotechnol. 9, 1736 (2013).
148. W. Zhang, D. Zhang, J. Tan, and H. Cong, Carbon nanotube exposure sensitize human ovarian cancer cells to paclitaxel. J. Nanosci. Nanotechnol. 12, 7211 (2012).
149. X. Zhang, X. He, Y. Li, Z. Zhang, Y. Ma, F. Li, and J. Liu, A cytotoxicity study of fluorescent carbon nanodots using human bronchial epithelial cells. J. Nanosci. Nanotechnol. 13, 5254 (2013).
150. X. Wang, B. Chen, X. Yang, J. Zhang, L. Zhao, and J. Tang, Functionalized superparamagnetic nanoparticles for highly-efficient gene delivery. J. Nanosci. Nanotechnol. 13, 746 (2013).
151. J. Wang, Z. Teng, Y. Tian, T. Fang, J. Ma, J. Sun, F. Zhu, J. Wu, X. Wang, N. Yang, X. Zhou, S. Yun, and G. Lu, Increasing cellular uptake of mesoporous silica nanoparticles in human embryonic kidney cell line 293T cells by using Lipofectamine 2000. J. Biomed. Nanotechnol. 9, 1882 (2013).
152. S. GhoshMitra, D. R. Diercks, N. C. Mills, D. A. Hynds, and S. Ghosh, Moderate level exposure to magnetic nanodots encased in tunable poly(ethylene glycol) analouge biopolymer shell do not deleteriously affect neurite outgrowth. J. Nanosci. Nanotechnol. 13, 8290 (2013).
153. M. Lin, J. Huang, and M. Sha, Recent advances in nanosized Mn-Zn ferrite magnetic fluid hyperthermia for cancer treatment. J. Nanosci. Nanotechnol. 14, 792 (2014).
154. T. Liu, H. Liu, C. Fu, L. Li, D. Chen, Y. Zhang, and F. Tang, Smaller silica nanorattles reabsorbed by intestinal aggravate multiple organs damage. J. Nanosci. Nanotechnol. 13, 6506 (2013).
155. K. G. Lee, J. S. Min, R. Wi, J. C. Kim, J. K. Ahn, and H. K. Do, Sonochemical preparation of silica nanorods for gene delivery using single-walled carbon nanotubes as templates. J. Nanosci. Nanotechnol. 11, 666 (2011).
156. D. Guo, H. Bi, Q. Wu, D. Wang, and Y. Cui, Zinc oxide nanoparticles induce rat retinal ganglion cell damage through Bcl-2, caspase- 9 and caspase-12 pathways. J. Nanosci. Nanotechnol. 13, 3769 (2013).
157. H. Zheng, L. J. Mortensen, and L. A. DeLouise, Thiol antioxidantfunctionalized CdSe/ZnS quantum dots: Synthesis, characterization, cytotoxicity. J. Biomed. Nanotechnol. 9, 382 (2013).
158. Y. Zhao, S. L. Lo, Y. Zheng, D. H. Lam, C. Wu, M. Y. Han, and S. Wang, Quantum dot coating of baculoviral vectors enables visualization of transduced cells and tissues. Biochem. Biophys. Res. Commun. 434, 110 (2013).
159. H. Wu, Y. Shi, C. Huang, Y. Zhang, J. Wu, H. Shen, and N. Jia, Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing. J. Biomater. Appl. 28, 1180 (2013).
160. L. Wang, G. Qin, S. Geng, Y. Dai, and J. Y. Wang, Preparation of zein conjugated quantum dots and their in vivo transdermal delivery capacity through nude mouse skin. J. Biomed. Nanotechnol. 9, 367 (2013).
161. D. Shao, Q. Zeng, Z. Fan, J. Li, M. Zhang, Y. Zhang, O. Li, L. Chen, X. Kong, and H. Zhang, Monitoring HSV-TK/ganciclovir cancer suicide gene therapy using CdTe/CdS core/shell quantum dots. Biomaterials 33, 4336 (2012).
162. L. Chong, C. H. Vannoy, M. O. Noor, and U. J. Krull, Intracellular nucleic acid interactions facilitated by quantum dots: Conceptualizing theranostics. Ther. Deliv. 3, 479 (2012).
163. S. P. Singh, Multifunctional magnetic quantum dots for cancer theranostics. J. Biomed. Nanotechnol. 7, 95 (2011).
164. A. Hoshino, N. Manabe, K. Fujioka, S. Hanada, M. Yasuhara, A. Kondo, and K. Yamamoto, GFP expression by intracellular gene delivery of GFP-coding fragments using nanocrystal quantum dots. Nanotechnology 19, 49 (2008).
165. Q. Wang, J. Chen, H. Zhang, M. Lu, D. Qiu, Y. Wen, and Q. Kong, Synthesis of water soluble quantum dots for monitoring carrier- DNA nanoparticles in plant cells. J. Nanosci. Nanotechnol. 11, 2208 (2011).
166. X. Liang, X. Li, J. Chang, Y. Duan, and Z. Li, Properties and evaluation of quaternized chitosan/lipid cation polymeric liposomes for cancer-targeted gene delivery. Langmuir 29, 8683 (2013).
167. N. S. Elbialy, B. M. Abdol-Azim, M. W. Shafaa, L. H. El Shazly, A. H. El Shazly, and W. A. Khalil, Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment. J. Biomed. Nanotechnol. 9, 2105 (2013).
168. A. L. de Barros, L. Mota, D. C. Soares, C. M. de Souza, G. D. Cassali, M. C. Oliveira, and V. N. Cardoso, Long-circulating, pHsensitive liposomes versus long-circulating, non-pH-sensitive liposomes as a delivery system for tumor identification. J. Biomed. Nanotechnol. 9, 1636 (2013).
169. C. W. Chen, M. K. Yeh, C. Y. Shiau, C. H. Chiang, and D. W. Lu, Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery. Int. J. Nanomedicine 8, 2613 (2013).
170. N. F. Sun, A. L. Tian, Y. X. Hua, S. Y. Hu, and A. B. Hu, Preparation and characterization of nano-liposome-mediated FL gene in the Lovo cells. Cancer Biother. Radiopharm. 27, 490 (2012).
171. Y. Negishi, Y. Endo-Takahashi, Y. Matsuki, Y. Kato, N. Takagi, R. Suzuki, K. Maruyama, and Y. Aramaki, Systemic delivery systems of angiogenic gene by novel bubble liposomes containing cationic lipid and ultrasound exposure. Mol. Pharm. 9, 1834 (2012).
172. D. Omata, Y. Negishi, S. Hagiwara, S. Yamamura, Y. Endo- Takahashi, R. Suzuki, K. Maruyama, M. Nomizu, and Y. Aramaki, Bubble liposomes and ultrasound promoted endosomal escape of TAT-PEG liposomes as gene delivery carriers. Mol. Pharm. 8, 2416 (2011).
173. L. C. Gomes-da-Silva, N. A. Fonseca, V. Moura, M. C. Pedroso de Lima, S. Simoes, and J. N. Moreira, Lipid-based nanoparticles for siRNA delivery in cancer therapy: Paradigms and challenges. Acc. Chem. Res. 45, 1163 (2012).
174. Z. H. Zhang, S. Abbad, R. R. Pan, A. Y. Waddad, L. L. Hou, H. X. Lv, and J. P. Zhou, N-octyl-N-Arginine chitosan micelles as an oral delivery system of insulin. J. Biomed. Nanotechnol. 9, 601 (2013).
175. K. Tanaka, T. Kanazawa, S. Horiuchi, T. Ando, K. Sugawara, Y. Takashima, Y. Seta, and H. Okada, Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery. Int. J. Pharm. 455, 40 (2013).
176. T. Y. Ohulchanskyy, A. Kopwitthaya, M. Jeon, M. Guo, W. C. Law, E. P. Furlani, C. Kim, and P. N. Prasad, Phospholipid micelle-based magneto-plasmonic nanoformulation for magnetic field-directed, imaging-guided photo-induced cancer therapy. Nanomedicine 9, 1192 (2013).
177. J. Li, Y. Wang, Y. Zhu, and D. Oupicky, Recent advances in delivery of drug-nucleic acid combinations for cancer treatment. J. Control. Release 172, 589 (2013).
178. J. Cao, S. Zhai, C. Li, B. He, Y. Lai, Y. Chen, X. Luo, and Z. Gu, Novel pH-sensitive micelles generated by star-shape copolymers containing zwitterionic sulfobetaine for efficient cellular internalization. J. Biomed. Nanotechnol. 9, 1847 (2013).
179. B. Xue, Y. Wang, X. Tang, P. Xie, F. Luo, C. Wu, and Z. Qian, Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery in vitro. J. Biomed. Nanotechnol. 8, 80 (2012).
180. V. Gajbhiye and S. Gong, Lectin functionalized nanocarriers for gene delivery. Biotechnol. Adv. 31, 552 (2013).
181. P. Prabhu and V. Patravale, The upcoming field of theranostic nanomedicine: An overview. J. Biomed. Nanotechnol. 8, 859 (2012).
182. H. Yin, P. S. Casey, and G. M. Chow, Nanocrystalline nickel ferrite particles synthesized by non-hydrolytic sol-gel method and their composite with biodegradable polymer. J. Nanosci. Nanotechnol. 12, 8431 (2012).
183. E. Hagtvet, T. J. Evjen, E. A. Nilssen, and D. R. Olsen, Assessment of liposome biodistribution by non-invasive optical imaging: A feasibility study in tumour-bearing mice. J. Nanosci. Nanotechnol. 12, 2912 (2012).
184. M. Zhou, L. Wang, W. Su, L. Tong, Y. Liu, Y. Fan, N. Luo, Y. Zheng, H. Zhao, R. Xiang, and Z. Li, Assessment of therapeutic efficacy of liposomal nanoparticles mediated gene delivery by molecular imaging for cancer therapy. J. Biomed. Nanotechnol. 8, 742 (2012).
185. Y. Sun, Z. Ji, Y. Zhao, X. Liang, X. Hu, and J. Fan, Enhanced distribution and anti-tumor activity of ergosta-4,6,8(14), 22-tetraen- 3-one by polyethylene glycol liposomalization. J. Nanosci. Nanotechnol. 13, 1435 (2013).
186. Y. Sun and Y. Zhao, Enhanced pharmacokinetics and anti-tumor efficacy of PEGylated liposomal rhaponticin and plasma protein binding ability of rhaponticin. J. Nanosci. Nanotechnol. 12, 7677 (2012).
187. L. Montenegro, A. Trapani, A. Latrofa, and G. Puglisi, In vitro evaluation on a model of blood brain barrier of idebenone-loaded solid lipid nanoparticles. J. Nanosci. Nanotechnol. 12, 330 (2012).
188. B. Zhang, Y. Lu, J. Chen, and W. Wu, Effects of interior gelation on pharmacokinetics and biodistribution of liposomes encapsulating an anti-cancer drug cytarabine. J. Biomed. Nanotechnol. 6, 704 (2010).
189. S. Bansod, S. Bonde, V. Tiwari, M. Bawaskar, S. Deshmukh, S. Gaikwad, A. Gade, and M. Rai, Bioconjugation of gold and silver nanoparticles synthesized by Fusarium oxysporum and their use in rapid identification of Candida species by using bioconjugatenano- polymerase chain reaction. J. Biomed. Nanotechnol. 9, 1962 (2013).
190. M. Shah, V. D. Badwaik, and R. Dakshinamurthy, Biological applications of gold nanoparticles. J. Nanosci. Nanotechnol. 14, 344 (2014).
191. S. Yi, L. Xia, S. C. Lenaghan, L. Sun, Y. Huang, J. N. Burris, C. N. Stewart, Jr., and M. Zhang, Bio-synthesis of gold nanoparticles using English ivy (Hedera helix). J. Nanosci. Nanotechnol. 13, 1649 (2013).
192. Y. J. Choi, Y. J. Kim, J. W. Lee, Y. Lee, S. Lee, Y. B. Lim, and H. W. Chung, Cytotoxicity and genotoxicity induced by photothermal effects of colloidal gold nanorods. J. Nanosci. Nanotechnol. 13, 4437 (2013).
193. Q. He, Z. Wu, and C. Huang, Hollow magnetic nanoparticles: Synthesis and applications in biomedicine. J. Nanosci. Nanotechnol. 12, 2943 (2012).
194. T. Kwon, H. J. Woo, Y. H. Kim, H. J. Lee, K. H. Park, S. Park, and B. Youn, Optimizing hemocompatibility of surfactant-coated silver nanoparticles in human erythrocytes. J. Nanosci. Nanotechnol. 12, 6168 (2012).
195. V. P. Venkatpurwar and V. B. Pokharkar, Biosynthesis of gold nanoparticles using therapeutic enzyme: In-vitro and in-vivo efficacy study. J. Biomed. Nanotechnol. 6, 667 (2010).
196. R. Goyal, S. K. Tripathi, S. Tyagi, A. Sharma, P. Kumar, K. R. Ram, D. K. Chowdhuri, Y. Shukla, and K. C. Gupta, In vitro and in vivo evaluation of linear polyethylenimine nanoparticles. J. Biomed. Nanotechnol. 7, 52 (2011).
197. S. Han, Y. Sun, S. Su, L. Hu, and Y. Wu, Amphiphilic poly(Laspartic acid) copolymer nanoparticles for cyclosporine A delivery. J. Nanosci. Nanotechnol. 13, 1444 (2013).
198. F. A. Dimer, A. R. Pohlmann, and S. S. Guterres, Characterization of rheology and release profiles of olanzapine-loaded lipid-core nanocapsules in thermosensitive hydrogel. J. Nanosci. Nanotechnol. 13, 8144 (2013).
199. P. Liu, H. Wang, Q. Wang, Y. Sun, M. Shen, M. Zhu, Z. Wan, and Y. Duan, cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil. J. Nanosci. Nanotechnol. 12, 4467 (2012).
200. R. Pradhan, B. K. Poudel, T. Ramasamy, H. G. Choi, C. S. Yong, and J. O. Kim, Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: Formulation, physicochemical characterization and cytotoxicity studies. J. Nanosci. Nanotechnol. 13, 5948 (2013).
201. J. H. Choi, S. R. Kang, H. Kim, S. H. Um, K. Shin, J. W. Choi, and B. K. Oh, Dye-doped silica nanoparticle with HIV-1 TAT peptide for bioimaging. J. Biomed. Nanotechnol. 9, 291 (2013).
202. Q. Li, D. Guo, R. Zhang, and X. Wang, Increasing anticancer drug internalization induced by new Au-MWCNTs nanocomposite. J. Nanosci. Nanotechnol. 12, 2192 (2012).
203. S. J. Lue, B. W. Chen, C. M. Shih, F. Y. Chou, J. Y. Lai, and W. Y. Chiu, Micron- and nano-sized poly(N-isopropylacrylamideco- acrylic acid) latex syntheses and their applications for controlled drug release. J. Nanosci. Nanotechnol. 13, 5305 (2013).
204. L. Li, X. Huang, T. Liu, H. Liu, N. Hao, D. Chen, Y. Zhang, and F. Tang, Overcoming multidrug resistance with mesoporous silica nanorods as nanocarrier of doxorubicin. J. Nanosci. Nanotechnol. 12, 4458 (2012).
205. J. Wang, H. Wang, X. Zhou, Z. Tang, G. Liu, and Q. Xia, Physicochemical characterization, photo-stability and cytotoxicity of coenzyme Q10-loading nanostructured lipid carrier. J. Nanosci. Nanotechnol. 12, 2136 (2012).
206. B. Moosa, K. Fhayli, S. Li, K. Julfakyan, A. Ezzeddine, and N. M. Khashab, Applications of nanodiamonds in drug delivery and catalysis. J. Nanosci. Nanotechnol. 14, 332 (2014).
207. V. R. Dhanak, Y. V. Butenko, A. C. Brieva, P. R. Coxon, L. Alves, and L. Miller, Chemical functionalization of nanodiamond by amino groups: An X-ray photoelectron spectroscopy study. J. Nanosci. Nanotechnol. 12, 3084 (2012).
208. H. L. Che, M. Muthiah, Y. Ahn, S. Son, W. J. Kim, H. Seonwoo, J. H. Chung, C. S. Cho, and I. K. Park, Biodegradable particulate delivery of vascular endothelial growth factor plasmid from polycaprolactone/ polyethylenimine electrospun nanofibers for the treatment of myocardial infarction. J. Nanosci. Nanotechnol. 11, 7073 (2011).
209. J. H. Yoo, I. S. Yoo, W. J. Yoon, and J. S. Kim, The detection of p53 gene via fluorescence quenching of quantum dot in microfluidic chip. J. Nanosci. Nanotechnol. 12, 4109 (2012).
210. J. H. Yoo and J. S. Kim, Identification of p53 gene by using CdSe/ZnS conjugation and hybridization. J. Nanosci. Nanotechnol. 11, 4343 (2011).
211. T. Gratieri, U. F. Schaefer, L. Jing, M. Gao, K. H. Kostka, R. F. Lopez, and M. Schneider, Penetration of quantum dot particles through human skin. J. Nanosci. Nanotechnol. 6, 586 (2010).
212. D. Wehrung, W. J. Geldenhuys, L. Bi, and M. O. Oyewumi, Biocompatibility, efficacy and biodistribution of Gelucire-stabilized nanoparticles engineered for docetaxel delivery. J. Nanosci. Nanotechnol. 12, 2901 (2012).
213. H. N. Noh and J. S. Kim, Detection of K-Ras oncogene using magnetic beads-quantum dots in microfluidic chip. J. Nanosci. Nanotechnol. 13, 5240 (2013).
214. J. Y. Lai, S. J. Lue, H. Y. Cheng, and D. H. Ma, Effect of matrix nanostructure on the functionality of carbodiimide cross-linked amniotic membranes as limbal epithelial cell scaffolds. J. Biomed. Nanotechnol. 9, 2048 (2013).
215. Y. Shi, Z. Wei, H. Zhao, T. Liu, A. Dong, and J. Zhang, Electrospinning of ibuprofen-loaded composite nanofibers for improving the performances of transdermal patches. J. Nanosci. Nanotechnol. 13, 3855 (2013).
216. F. Yao, H. S. Wang, and G. D. Fu, Electrospinning-directed onedimensional alignment of core-shell silica/polymer nanoparticles in nanofibers. J. Nanosci. Nanotechnol. 12, 7284 (2012).
217. L. G. Santos, D. C. Oliveira, M. S. Santos, L. M. Neves, F. O. de Gaspi, F. A. Mendonca, M. A. Esquisatto, G. M. Santos, M. A. d'Avila, and L. H. Mei, Electrospun membranes of poly(lactic acid) (PLA) used as scaffold in drug delivery of extract of Sedum dendroideum. J. Nanosci. Nanotechnol. 13, 4694 (2013).
218. Y. T. Huang, H. T. Lee, and C. W. Lai, Engineering of the growth environment of microalgae with high biomass and lipid productivity. J. Nanosci. Nanotechnol. 13, 2117 (2013).
219. J. Ryu, B. Cho, H. G. Woo, S. Cho, and H. Sohn, Fabrication and characterization of photoluminescent silicon nanoparticles for drug delivery applications. J. Nanosci. Nanotechnol. 13, 157 (2013).
220. Y. Wang, Y. Ma, Y. Du, Z. Liu, D. Zhang, and Q. Zhang, Formulation and pharmacokinetics evaluation of puerarin nanocrystals for intravenous delivery. J. Nanosci. Nanotechnol. 12, 6176 (2012).
221. J. H. Yang, H. Jung, S. Y. Kim, C. H. Yo, and J. H. Choy, Heterostructured layered aluminosilicate-itraconazole nanohybrid for drug delivery system. J. Nanosci. Nanotechnol. 13, 7331 (2013).
222. J. Shilpa, T. R. Anju, M. S. Ajayan, and C. S. Paulose, Increased cortical neuronal survival during liver injury: Effect of gamma aminobutyric acid and 5-HT chitosan nanoparticles. J. Biomed. Nanotechnol. 10, 622 (2014).
223. P. Ghosh, T. Noda, and M. Tanemura, Morphology-tuned fabrication of highly transparent and flexible nanostructures at room temperature. J. Nanosci. Nanotechnol. 13, 5767 (2013).
224. Y. Wang, B. Chang, and W. Yang, pH-sensitive polyketal nanoparticles for drug delivery. J. Nanosci. Nanotechnol. 12, 8266 (2012).
225. Q. Xu, N. Zhang, W. Qin, J. Liu, Z. Jia, and H. Liu, Preparation, in vitro and in vivo evaluation of budesonide loaded core/shell nanofibers as oral colonic drug delivery system. J. Nanosci. Nanotechnol. 13, 149 (2013).
226. Q. Y. Cheng and B. H. Han, Supramolecular hydrogel based on graphene oxides for controlled release system. J. Nanosci. Nanotechnol. 13, 755 (2013).
227. S. Lai, W. Zhang, F. Liu, C. Wu, D. Zeng, Y. Sun, Y. Xu, Y. Fang, and W. Zhou, TiO2 nanotubes as animal drug delivery system and in vitro controlled release. J. Nanosci. Nanotechnol. 13, 91 (2013).
228. Q. Liu, J. Zhang, W. Xia, and H. Gu, Towards magnetic-enhanced cellular uptake, MRI and chemotherapeutics delivery by magnetic mesoporous silica nanoparticles. J. Nanosci. Nanotechnol. 12, 7709 (2012).
229. A. O. Hassan and A. H. Elshafeey, Nanosized particulate systems for dermal and transdermal delivery. J. Biomed. Nanotechnol. 6, 621 (2010).
230. E. Valarezo, M. Stanzione, L. Tammaro, L. Cartuche, O. Malagon, and V. Vittoria, Preparation, characterization and antibacterial activity of poly(epsilon-caprolactone) electrospun fibers loaded with amoxicillin for controlled release in biomedical applications. J. Nanosci. Nanotechnol. 13, 1717 (2013).
231. M. Muthiah, S. J. Lee, M. Moon, H. J. Lee, W. K. Bae, I. J. Chung, Y. Y. Jeong, and I. K. Park, Surface tunable polymersomes loaded with magnetic contrast agent and drug for image guided cancer therapy. J. Nanosci. Nanotechnol. 13, 1626 (2013).
232. N. Ma, C. Ma, C. Li, T. Wang, Y. Tang, H. Wang, X. Mou, Z. Chen, and N. He, Influence of nanoparticle shape, size, and surface functionalization on cellular uptake. J. Nanosci. Nanotechnol. 13, 6485 (2013).
233. D. Vercauteren, J. Rejman, T. F. Martens, J. Demeester, S. C. De Smedt, and K. Braeckmans, On the cellular processing of non-viral nanomedicines for nucleic acid delivery: mechanisms and methods. J. Control. Release 161, 566 (2012).
234. T. U. Ly, N. Q. Tran, T. K. Hoang, K. N. Phan, H. N. Truong, and C. K. Nguyen, Pegylated dendrimer and its effect in fluorouracil loading and release for enhancing antitumor activity. J. Biomed. Nanotechnol. 9, 213 (2013).
235. S. Mignani, S. El Kazzouli, M. Bousmina, and J. P. Majoral, Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview. Adv. Drug Deliv. Rev. 65, 1316 (2013).
236. Y. J. Choi, Y. J. Kim, J. W. Lee, Y. Lee, Y. B. Lim, and H. W. Chung, Cyto-/genotoxic effect of CdSe/ZnS quantum dots in human lung adenocarcinoma cells for potential photodynamic UV therapy applications. J. Nanosci. Nanotechnol. 12, 2160 (2012).
237. R. Aalinkeel, B. Nair, J. L. Reynolds, D. E. Sykes, W. C. Law, S. D. Mahajan, P. N. Prasad, and S. A. Schwartz, Quantum rods as nanocarriers of gene therapy. Drug Deliv. 19, 220 (2012).
238. M. Griep, E. Winder, D. Lueking, C. Friedrich, G. Mallick, and S. Karna, Optical protein modulation via quantum dot coupling and use of a hybrid sensor protein. J. Nanosci. Nanotechnol. 10, 6029 (2010).
239. Y. Sun, X. Li, X. Liang, Z. Wan, and Y. Duan, Calcium phosphate/octadecyl-quatemized carboxymethyl chitosan nanoparticles: An efficient and promising carrier for gene transfection. J. Nanosci. Nanotechnol. 13, 5260 (2013).
240. S. Xu, Q. Xu, J. Zhou, J. Wang, N. Zhang, and L. Zhang, Preparation and characterization of folate-chitosan-gemcitabine core-shell nanoparticles for potential tumor-targeted drug delivery. J. Nanosci. Nanotechnol. 13, 129 (2013).
241. Y. Qiu, J. Zhu, J. Wang, R. Gong, M. Zheng, and F. Huang, Selfassembled phytosterol-fructose-chitosan nanoparticles as a carrier of anticancer drug. J. Nanosci. Nanotechnol. 13, 5935 (2013).
242. R. C. Nagarwal, P. N. Singh, S. Kant, P. Maiti, and J. K. Pandit, Chitosan coated PLA nanoparticles for ophthalmic delivery: Characterization, in-vitro and in-vivo study in rabbit eye. J. Biomed. Nanotechnol. 6, 648 (2010).
243. M. de la Fuente, B. Seijo, and M. J. Alonso, Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue. Gene Ther. 15, 668 (2008).
244. M. Ravina, E. Cubillo, D. Olmeda, R. Novoa-Carballal, E. Fernandez-Megia, R. Riguera, A. Sanchez, A. Cano, and M. J. Alonso, Hyaluronic acid/chitosan-g-poly(ethylene glycol) nanoparticles for gene therapy: an application for pDNA and siRNA delivery. Pharm. Res. 27, 2544 (2010).
245. M. Sivasubramanian, T. Thambi, V. G. Deepagan, G. Saravanakumar, H. Ko, Y. M. Kang, and J. H. Park, Carboxymethyl dextran-cyclodextrin conjugate as the carrier of doxorubicin. J. Nanosci. Nanotechnol. 13, 7271 (2013).
246. D. Teijeiro-Osorio, C. Remunan-Lopez, and M. J. Alonso, Chitosan/ cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro. Eur. J. Pharm. Biopharm. 71, 257 (2009).
247. T. H. Kim, H. Choi, G. S. Yu, and J. S. Choi, Synthesis of polyethylene glycol-oligo (glutamic acid) conjugated with polyethylenimine-dexamethasone for gene delivery applications. J. Nanosci. Nanotechnol. 13, 7325 (2013).
248. C. Wang, J. Liang, X. Deng, C. Long, C. Xie, X. Chen, L. Zhang, Q. Guo, Y. Wang, F. Luo, and Z. Qian, Synthesis, characterization, and application of amino-terminated poly(ethylene glycol)-blockpoly( epsilon-caprolactone) copolymer for paclitaxel. J. Nanosci. Nanotechnol. 13, 68 (2013).
249. E. Mornet, N. Carmoy, C. Laine, L. Lemiegre, T. Le Gall, I. Laurent, R. Marianowski, C. Ferec, P. Lehn, T. Benvegnu, and T. Montier, Folate-equipped nanolipoplexes mediated efficient gene transfer into human epithelial cells. Int. J. Mol. Sci. 14, 1477 (2013).
250. M. Morille, T. Montier, P. Legras, N. Carmoy, P. Brodin, B. Pitard, J. P. Benoit, and C. Passirani, Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials 31, 321 (2010).
251. J. Yang, E. S. Lee, M. Y. Noh, S. H. Koh, E. K. Lim, A. R. Yoo, K. Lee, J. S. Suh, S. H. Kim, S. Haam, and Y. M. Huh, Ambidextrous magnetic nanovectors for synchronous gene transfection and labeling of human MSCs. Biomaterials 32, 6174 (2011).
252. F. Geinguenaud, I. Souissi, R. Fagard, L. Motte, and Y. Lalatonne, Electrostatic assembly of a DNA superparamagnetic nano-tool for simultaneous intracellular delivery and in situ monitoring. Nanomedicine 8, 1106 (2012).
253. J. R. Viola, H. Leijonmarck, O. E. Simonson, Oprea, II, R. Frithiof, P. Purhonen, P. M. Moreno, K. E. Lundin, R. Stromberg, and C. I. Smith, Fatty acid-spermine conjugates as DNA carriers for nonviral in vivo gene delivery. Gene Ther. 16, 1429 (2009).
254. M. Shiota, Y. Ikeda, Z. Kaul, J. Itadani, S. C. Kaul, and R. Wadhwa, Internalizing antibody-based targeted gene delivery for human cancer cells. Hum. Gene Ther. 18, 1153 (2007).
255. J. H. Kim, Y. K. Kim, M. T. Arash, S. H. Hong, J. H. Lee, B. N. Kang, Y. B. Bang, C. S. Cho, D. Y. Yu, H. L. Jiang, and M. H. Cho, Galactosylation of chitosan-graft-spermine as a gene carrier for hepatocyte targeting in vitro and in vivo. J. Nanosci. Nanotechnol. 12, 5178 (2012).
256. D. J. Glover, S. M. Ng, A. Mechler, L. L. Martin, and D. A. Jans, Multifunctional protein nanocarriers for targeted nuclear gene delivery in nondividing cells. FASEB J. 23, 2996 (2009).
257. C. H. Jones, C. K. Chen, M. Jiang, L. Fang, C. Cheng, and B. A. Pfeifer, Synthesis of cationic polylactides with tunable charge densities as nanocarriers for effective gene delivery. Mol. Pharm. 10, 1138 (2013).
258. S. David, T. Montier, N. Carmoy, P. Resnier, A. Clavreul, M. Mevel, B. Pitard, J. P. Benoit, and C. Passirani, Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma model. J. Gene Med. 14, 769 (2012).
259. M. Kato, Y. Hattori, M. Kubo, and Y. Maitani, Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex. Int. J. Pharm. 423, 428 (2012).
260. M. Khalaj-Kondori, M. Sadeghizadeh, M. Behmanesh, I. Saggio, and P. Monaci, Chemical coupling as a potent strategy for preparation of targeted bacteriophage-derived gene nanocarriers into eukaryotic cells. J. Gene Med. 13, 622 (2011).
261. B. Ozpolat, A. K. Sood, and G. Lopez-Berestein, Nanomedicine based approaches for the delivery of siRNA in cancer. J. Intern. Med. 267, 44 (2010).
262. W. M. Merritt, Y. G. Lin, L. Y. Han, A. A. Kamat, W. A. Spannuth, R. Schmandt, D. Urbauer, L. A. Pennacchio, J. F. Cheng, A. M. Nick, M. T. Deavers, A. Mourad-Zeidan, H. Wang, P. Mueller, M. E. Lenburg, J. W. Gray, S. Mok, M. J. Birrer, G. Lopez- Berestein, R. L. Coleman, M. Bar-Eli, and A. K. Sood, Dicer, Drosha, and outcomes in patients with ovarian cancer. N. Engl. J. Med. 359, 2641 (2008).
263. Y. K. Kim, C. S. Cho, M. H. Cho, and H. L. Jiang, Poly(ester amine) synthesized from trimethylolpropane triacrylate and spermine as an efficient siRNA carrier. J. Nanosci. Nanotechnol. 13, 5692 (2013).
264. M. Muthiah, M. A. Islam, C. S. Cho, J. E. Hwang, I. J. Chung, and I. K. Park, Substrate-mediated delivery of microRNA-145 through a polysorbitol-based osmotically active transporter suppresses smooth muscle cell proliferation: implications for restenosis treatment. J. Biomed. Nanotechnol. 10, 571 (2014).
265. H. Y. Yoon, H. R. Kim, G. Saravanakumar, R. Heo, S. Y. Chae, W. Um, K. Kim, I. C. Kwon, J. Y. Lee, D. S. Lee, J. C. Park, and J. H. Park, Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting. J. Control. Release 172, 653 (2013).
266. M. Susa, A. K. Iyer, K. Ryu, E. Choy, F. J. Hornicek, H. Mankin, L. Milane, M. M. Amiji, and Z. Duan, Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS One 5, 10764 (2010).
267. L. De Backer, K. Braeckmans, J. Demeester, S. C. De Smedt, and K. Raemdonck, The influence of natural pulmonary surfactant on the efficacy of siRNA-loaded dextran nanogels. Nanomedicine 8, 1625 (2013).
268. S. J. Lee, H. J. Lee, M. J. Moon, H. Vu-Quang, M. Muthiah, H. L. Che, S. U. Heo, H. J. Jeong, Y. Y. Jeong, and I. K. Park, Superparamagnetic iron oxide nanoparticles-loaded polymersomemediated gene delivery guided by enhanced magnetic resonance signal. J. Nanosci. Nanotechnol. 11, 7057 (2011).
269. Y. Chen, W. Wang, G. Lian, C. Qian, L. Wang, L. Zeng, C. Liao, B. Liang, B. Huang, K. Huang, and X. Shuai, Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer. Int. J. Nanomedicine. 7, 359 (2012).
270. P. Ofek, W. Fischer, M. Calderon, R. Haag, and R. Satchi-Fainaro, In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers. FASEB J. 24, 3122 (2010).
271. T. Lobovkina, G. B. Jacobson, E. Gonzalez-Gonzalez, R. P. Hickerson, D. Leake, R. L. Kaspar, C. H. Contag, and R. N. Zare, In vivo sustained release of siRNA from solid lipid nanoparticles. ACS Nano 5, 9977 (2011).
272. M. L. Patil, M. Zhang, and T. Minko, Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing. ACS Nano 5, 1877 (2011).
273. S. Son, S. Song, S. J. Lee, S. Min, S. A. Kim, J. Y. Yhee, M. S. Huh, I. C. Kwon, S. Y. Jeong, Y. Byun, S. H. Kim, and K. Kim, Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors. Biomaterials 34, 9475 (2013).
274. S. R. Youngren, R. K. Tekade, B. Gustilo, P. R. Hoffmann, and M. B. Chougule, STAT6 siRNA matrix-loaded gelatin nanocarriers: Formulation, characterization, and ex vivo proof of concept using adenocarcinoma cells. Biomed. Res. Int. 2013, 858946 (2013).
275. C. Bouclier, V. Marsaud, O. Bawa, V. Nicolas, L. Moine, P. Opolon, and J. M. Renoir, Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor alpha and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts. Breast Cancer Res. Treat. 122, 145 (2010).
276. N. Nafee, M. Schneider, K. Friebel, M. Dong, U. F. Schaefer, T. E. Murdter, and C. M. Lehr, Treatment of lung cancer via telomerase inhibition: Self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2-O-Methyl-RNA. Eur. J. Pharm. Biopharm. 80, 478 (2012).
277. G. M. Seo, R. S. Rachakatla, S. Balivada, M. Pyle, T. B. Shrestha, M. T. Basel, C. Myers, H. Wang, M. Tamura, S. H. Bossmann, and D. L. Troyer, A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma. Mol. Biol. Rep. 39, 157 (2012).
278. P. Zarogoulidis, K. Darwiche, A. Sakkas, L. Yarmus, H. Huang, Q. Li, L. Freitag, K. Zarogoulidis, and M. Malecki, Suicide gene therapy for cancer-current strategies. J. Genet. Syndr. Gene Ther. 4, 16849 (2013).
279. R. Ortiz, J. Prados, C. Melguizo, J. L. Arias, M. A. Ruiz, P. J. Alvarez, O. Caba, R. Luque, A. Segura, and A. Aranega, 5- Fluorouracil-loaded poly(epsilon-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer. Int. J. Nanomedicine 7, 95 (2012).
280. Y. H. Huang, G. T. Zugates, W. Peng, D. Holtz, C. Dunton, J. J. Green, N. Hossain, M. R. Chernick, R. F. Padera, Jr., R. Langer, D. G. Anderson, and J. A. Sawicki, Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice. Cancer Res. 69, 6184 (2009).
281. A. K. Bouzier-Sore, E. Ribot, V. Bouchaud, S. Miraux, E. Duguet, S. Mornet, G. Clofent-Sanchez, J. M. Franconi, and P. Voisin, Nanoparticle phagocytosis and cellular stress: Involvement in cellular imaging and in gene therapy against glioma. NMR Biomed. 23, 88 (2010).
282. Y. Hattori and Y. Maitani, Two-step transcriptional amplificationlipid- based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer. Cancer Sci. 97, 787 (2006).
283. J. Czupryna and A. Tsourkas, Suicide gene delivery by calcium phosphate nanoparticles: A novel method of targeted therapy for gastric cancer. Cancer Biol. Ther. 5, 1691 (2006).
284. W. Peng, D. G. Anderson, Y. Bao, R. F. Padera, Jr., R. Langer, and J. A. Sawicki, Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors. Prostate 67, 855 (2007).
285. P. Voisin, E. J. Ribot, S. Miraux, A. K. Bouzier-Sore, J. F. Lahitte, V. Bouchaud, S. Mornet, E. Thiaudiere, J. M. Franconi, L. Raison, C. Labrugere, and M. H. Delville, Use of lanthanide-grafted inorganic nanoparticles as effective contrast agents for cellular uptake imaging. Bioconjug. Chem. 18, 1053 (2007).
286. D. Yu, A. Wang, H. Huang, and Y. Chen, PEG-PBLG nanoparticlemediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma. Nanomedicine 3, 813 (2008).
287. V. Cebrian, F. Martin-Saavedra, C. Yague, M. Arruebo, J. Santamaria, and N. Vilaboa, Size-dependent transfection efficiency of PEI-coated gold nanoparticles. Acta Biomater. 7, 3645 (2011).
288. A. K. Sahoo, S. Banerjee, S. S. Ghosh, and A. Chattopadhyay, Simultaneous RGB emitting Au nanoclusters in chitosan nanoparticles for anticancer gene theranostics. ACS Appl. Mater. Interfaces 6, 712 (2014).
289. X. Sun, G. Zhang, R. S. Keynton, M. G. O'Toole, D. Patel, and A. M. Gobin, Enhanced drug delivery via hyperthermal membrane disruption using targeted gold nanoparticles with PEGylated Protein-G as a cofactor. Nanomedicine 9, 1214 (2013).
290. G. Tiramt, A. Scomparin, P. Ofek, and R. Satchi-Fainaro, Interfering cancer with polymeric siRNA nanomedicines. J. Biomed. Nanotechnol. 10, 50 (2014).
291. V. E. de Campos, E. Ricci- Junior, and C. R. Mansur, Nanoemulsions as delivery systems for lipophilic drugs. J. Nanosci. Nanotechnol. 12, 2881 (2012).
292. H. Shi, Y. Huang, C. Cheng, G. Ji, Y. Yang, and H. Yuan, Preparation and characterization of chain-like and peanut-like Fe3O4@SiO2 core-shell structure. J. Nanosci. Nanotechnol. 13, 6953 (2013).
293. J. M. Li, Y. Y. Wang, M. X. Zhao, C. P. Tan, Y. Q. Li, X. Y. Le, L. N. Ji, and Z. W. Mao, Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking. Biomaterials 33, 2780 (2012).
294. H. O. Kim, E. Kim, Y. An, J. Choi, E. Jang, E. B. Choi, A. Kukreja, M. H. Kim, B. Kang, D. J. Kim, J. S. Suh, Y. M. Huh, and S. Haam, A biodegradable polymersome containing Bcl-xL siRNA and doxorubicin as a dual delivery vehicle for a synergistic anticancer effect. Macromol. Biosci. 13, 745 (2013).
295. K. Nakamura, A. S. Abu Lila, M. Matsunaga, Y. Doi, T. Ishida, and H. Kiwada, A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA. Mol. Ther. 19, 2040 (2011).
296. D. W. Dong, B. Xiang, W. Gao, Z. Z. Yang, J. Q. Li, and X. R. Qi, pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells. Biomaterials 34, 4849 (2013).
297. J. H. Kang, J. Oishi, J. H. Kim, M. Ijuin, R. Toita, B. Jun, D. Asai, T. Mori, T. Niidome, K. Tanizawa, S. Kuroda, and Y. Katayama, Hepatoma-targeted gene delivery using a tumor cell-specific gene regulation system combined with a human liver cell-specific bionanocapsule. Nanomedicine 6, 583 (2010).
298. Z. Chen, M. F. Penet, S. Nimmagadda, C. Li, S. R. Banerjee, P. T. Winnard, Jr., D. Artemov, K. Glunde, M. G. Pomper, and Z. M. Bhujwalla, PSMA-targeted theranostic nanoplex for prostate cancer therapy. ACS Nano 6, 7752 (2012).
299. E. Salva, S. O. Turan, L. Kabasakal, S. Alan, N. Ozkan, F. Eren, and J. Akbuga, Investigation of the Therapeutic efficacy of codelivery of psiRNA-vascular endothelial growth factor and pIL-4 into chitosan nanoparticles in the breast tumor model. J. Pharm. Sci. 103, 785 (2013).
300. N. Rozanova and J. Z. Zhang, Metal and magnetic nanostructures for cancer diagnosis and therapy. Rev. Nanosci. Nanotechnol. 2, 29 (2013).
301. J. Barar and Y. Omidi, Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goals. Bioimpacts 3, 105 (2013).
302. W. Chen, Welcome to the Reviews in Nanoscience and Nanotechnology. Rev. Nanosci. Nanotechnol. 1, 1 (2012).
303. Jagbir Singh, W. Mohammed-Saied, R. Kaur, and I. Badea, Nanoparticles in gene therapy: From design to clinical applications. Rev. Nanosci. Nanotechnol. 2, 275 (2013).
304. W. Lu and Y. Zu, Metal-based nanoparticles: Their potential clinical applications and limitations. Rev. Nanosci. Nanotechnol. 2, 208 (2013).
305. S. L. Christensen, J. D. Padmos, A. Chatt, and P. Zhang, Preparation and orthopaedic applications of nanoparticle-modified biocompatible surfaces. Rev. Nanosci. Nanotechnol. 2, 63 (2013).